• Socioeconomic Impact of Hospitalization Expenditure for Treatment of Noncommunicable Diseases in India: A Repeated Cross-Sectional Analysis of National Sample Survey Data, 2004 to 2018

    May 1, 2021, 00:00

  • A Cost-Effectiveness Analysis of Neuraminidase Inhibitors for Influenza Virus Infections in an Adult-Outpatient Setting in Japan

    May 1, 2021, 00:00

  • Cost-Effectiveness of Lenvatinib in the Treatment of Patients With Unresectable Hepatocellular Carcinomas in Japan: An Analysis Using Data From Japanese Patients in the REFLECT Trial

    May 1, 2021, 00:00

  • Current Development and Practice of Pharmacoeconomic Evaluation Guidelines for Universal Health Coverage in China

    May 1, 2021, 00:00

  • Patient Journey and Disease-Related Burden in Japanese Patients With Chronic Thromboembolic Pulmonary Hypertension: A Mixed Methods Study [Editor's Choice]

    May 1, 2021, 00:00

  • Economic Burden of Stroke in Iran: A Population-Based Study

    May 1, 2021, 00:00

  • Social and Economic Costs and Health-Related Quality of Life in Patients With Acute Coronary Syndrome

    May 1, 2021, 00:00

  • Validity of the Malay EQ-5D-3L in the Malaysian Transfusion-Dependent Thalassemia Population

    May 1, 2021, 00:00

  • Reviewer Acknowledgment

    Dec 16, 2020, 17:31

  • Copyright/Subscription

    Dec 9, 2020, 11:53

  • How Educational Inequalities in Cardiovascular Mortality Evolve While Healthcare Insurance Coverage Grows: Colombia, 1998 to 2015

    Dec 1, 2020, 00:00

  • Cost Analysis of Cancer in Brazil: A Population-Based Study of Patients Treated by Public Health System From 2001-2015 (Editor's Choice)

    Dec 1, 2020, 00:00

  • Cost-Effectiveness of the Addition of Bevacizumab to First-Line Chemotherapy With Carboplatin and Paclitaxel in Patients With Non–Small Cell Lung Cancer

    Dec 1, 2020, 00:00

  • International Experience in Therapeutic Value and Value-Based Pricing: A Rapid Review of the Literature

    Dec 1, 2020, 00:00

  • Satisfaction With Healthcare Services Among Patients With Diabetes, Hypertension, and/or Dyslipidemia in Mexico: A Cross-Sectional Study

    Dec 1, 2020, 00:00

  • Editorial Board

    Dec 1, 2020, 00:00

  • Is There Something Else Beyond Cost-Effectiveness Analysis for Public Health Decision Making?

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis and Budget Impact: Antimuscarinics and Mirabegron for the Treatment of Patients With Urge Urinary Incontinence: The Brazilian Public Health System Perspective

    Dec 1, 2020, 00:00

  • Cost-Effectiveness of Natalizumab Compared With Fingolimod for Relapsing-Remitting Multiple Sclerosis Treatment in Colombia

    Dec 1, 2020, 00:00

  • 24/7 Physical Therapy Intervention With Adult Patients in a Chilean Intensive Care Unit: A Cost-Benefit Analysis in a Developing Country

    Dec 1, 2020, 00:00

  • Willingness of Infertile Couples to Pay for In Vitro Fertilization Treatment in the Integrated Human Reproduction Section of the Escola Paulista de Medicina, São Paulo Federal University

    Dec 1, 2020, 00:00

  • What Do Doctors Think About Value-Based Healthcare? A Survey of Practicing Physicians in a Private Healthcare Provider in Brazil (Editor's Choice)

    Dec 1, 2020, 00:00

  • Omitted Conflict of Interest Disclosures in Previously Published Articles

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Rehabilitation Interventions for Teeth With Extensive Coronary Destruction

    Dec 1, 2020, 00:00

  • Implementing Health Technology Assessments in Latin America: Looking at the Past, Mirroring the Future. A Perspective from the ISPOR Health Technology Assessment Roundtable in Latin America (Editor's Choice)

    Dec 1, 2020, 00:00

  • Multi-Criteria Model for Evaluating Drugs to Prevent Deep Venous Thrombosis Associated With Orthopedic Surgery: A Hospital-Based Case Study

    Dec 1, 2020, 00:00

  • Limitations and Challenges of Conducting Budget Impact Analyses in Rare Diseases: A Case Study of Alpha-1 Antitrypsin Deficiency (Editor's Choice)

    Dec 1, 2020, 00:00

  • Cost-Effectiveness Analysis of Point-of-Care Rapid Testing Versus Laboratory-Based Testing for Antenatal Screening of Syphilis in Brazil

    Dec 1, 2020, 00:00

  • Treatment Satisfaction Questionnaire for Medication (TSQM version 1.4): Ceiling and Floor Effects, Reliability, and Known-Group Validity in Brazilian Outpatients With Hypertension

    Dec 1, 2020, 00:00

  • Costs Associated With Early Vascular and Biliary Complications in Liver-Transplanted Patients in a Hospital in Antioquia, Colombia 2019: A Case Series

    Dec 1, 2020, 00:00

  • Adaptation and Validation of the Health Belief Model Scale for Breast Self-Examination in Mexican Women

    Dec 1, 2020, 00:00

  • Table of Contents

    Dec 1, 2020, 00:00

  • Cost and Effectiveness of the Treatment of Chronic Hepatitis C in Brazil: Real-World Data (Editor's Choice)

    Dec 1, 2020, 00:00

  • Treatment With Liposomal Amphotericin B for All Confirmed Cases of Human Visceral Leishmaniasis in Brazil: A Budget Impact Analysis

    Dec 1, 2020, 00:00

  • Copyright/Subscription

    Sep 12, 2020, 10:30

  • PNS16 Health and Economic Burden of Smoking in Indonesia

    Sep 1, 2020, 00:00

  • PMD1 Effectiveness and Cost Analysis for Peripheral Inserted Central Catheter VS Central Venous Catheter in China

    Sep 1, 2020, 00:00

  • PMD11 Efficacy of Stereotactic Body Radiotherapy for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis

    Sep 1, 2020, 00:00

  • PIN50 Hepatitis B and C: Differences in Diagnosis and Treatment

    Sep 1, 2020, 00:00

  • PCN95 A Systematic Literature Review of the Use of Mhealth Apps to Improve Quality of Life (QOL) in Cancer Patients

    Sep 1, 2020, 00:00

  • PDG23 Exploring the Determinants of Pharmaceutical Expenditure Growth: The Case of Cancer Drugs UNDER a Single-Payer System

    Sep 1, 2020, 00:00

  • PDG17 The Economic IMPACT Analysis of a Proposal to Abandon NON-Prescription Drug Reimbursement in Thailand, a Case Study of NON-Sedating Antihistamines

    Sep 1, 2020, 00:00

  • PNS53 Differences in Evidence Reviews Requirements for Health Technology Assessment (HTA) Document Development between Selected Countries

    Sep 1, 2020, 00:00

  • PNS38 Creation of Favorable Conditions for the Development of the Clinical Trials Market

    Sep 1, 2020, 00:00

  • PSU10 The IMPACT of Post-Operative Complications on in-Hospital Cost Among 8130 Patients Undergoing Distal Gastrectomy in JAPAN: A Nationwide Registry Study

    Sep 1, 2020, 00:00

  • PCN30 Comparison of Health Status Utilities of Breast Cancer with Comorbidities from the Korean National Health and Nutrition Examination Survey (KNHANES) 2008-2018

    Sep 1, 2020, 00:00

  • PIH13 Medications Risk and Pregnancy: Knowledge, Attitude, and Practice of Pharmacists in Gondar TOWN, North WEST Ethiopia. a CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PRS1 Comparison of Clinical Outcomes Associated with Different Inhaler Devices in Asthma and COPD

    Sep 1, 2020, 00:00

  • PCN49 Disease Burden of Classical Hodgkin Lymphoma UNDER Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PCN36 Cost-Effectiveness Analysis of Pembrolizumab Versus Nivolumab As the First-LINE Treatment for Advanced and Metastatic NON-SMALL CELL LUNG Cancer in Germany

    Sep 1, 2020, 00:00

  • PSU8 Health Economic Evaluation of Protocol Change Including IV Iron Ferric Carboxymaltose Versus Control Group for HIP Surgery Patients with Iron Deficiency Anemia (IDA) in Korea

    Sep 1, 2020, 00:00

  • PRO5 IMPACT of Prophylaxis Costs in a Pediatric Patient Diagnosed with Severe Hemophilia a with Inhibitors in Guayaquil, Ecuador

    Sep 1, 2020, 00:00

  • PIN37 Projection of Covid-19 Based on Decision Tree Analysis: WE Have NOT Won but WE Have NOT Lost the WAR!

    Sep 1, 2020, 00:00

  • PCV1 Cardiac Rehabilitation Program in a Tertiary Hospital in Peninsular Malaysia: Outcome and Associations

    Sep 1, 2020, 00:00

  • PCV13 Health Economic Evaluation of Screening and Treating Children with Familial Hypercholesterolemia EARLY in Life: Many Happy Returns on Investment?

    Sep 1, 2020, 00:00

  • Cefuroxime (Aprokam®) in the Prophylaxis of Postoperative Endophthalmitis After Cataract Surgery Versus Absence of Antibiotic Prophylaxis: A Cost-Effectiveness Analysis in Poland

    Sep 1, 2020, 00:00

  • PNS49 Building Capacity for HTA in the Philippines: An Imperative UNDER UHC

    Sep 1, 2020, 00:00

  • PNS27 Diffusion of Pharmaceutical Innovations in the Public Healthcare Setting in Malaysia

    Sep 1, 2020, 00:00

  • PMS6 Incidence and Prevalence of Osteoporosis and Related Fractures in ASIA and the Pacific: A Systematic Review

    Sep 1, 2020, 00:00

  • PIN31 The Epidemiology and Cost of Dengue Disease in Thailand: A Systematic Literature Review

    Sep 1, 2020, 00:00

  • PCV20 A Real-World Study of Patient Characteristics and Treatment Patterns for Atrial Fibrillation in China

    Sep 1, 2020, 00:00

  • PMU11 Current Status of the Use of Prescription Opioids in Korean Elderly Patients: An Analysis of the Health Insurance Review and Assessment Service-Aged Patient Sample DATA

    Sep 1, 2020, 00:00

  • PNS72 Patients Are Playing an Increasing Role in Medical Decisions Due to the Digital Transformation of Healthcare in China

    Sep 1, 2020, 00:00

  • PCV6 MODEL-Based Evaluation on Annual Economic Burden of Coronary Atherosclerotic Heart Disease in China

    Sep 1, 2020, 00:00

  • PCN80 Comparison of Treatment Among Chronic Myeloid Leukemia Patients in China and United States: Results of Primary Market Research Survey of Oncologists

    Sep 1, 2020, 00:00

  • PMS14 CHILD with Cerebral Palsy Benefited from Motor Sequencing Training: Case Report

    Sep 1, 2020, 00:00

  • PGI7 Cost-Effectiveness Analysis of Vonoprazan Versus Proton Pump Inhibitors in the Treatment of Reflux Esophagitis in China

    Sep 1, 2020, 00:00

  • Table of Contents

    Sep 1, 2020, 00:00

  • PCN38 Cost-Effectiveness of Mammography As a Screening Test for EARLY Detection of Breast Cancer

    Sep 1, 2020, 00:00

  • PIN45 Comparison of Antibiotics Policies between European Union Countries and JAPAN

    Sep 1, 2020, 00:00

  • PMU8 The Increasing Burden of NON-Communicable Diseases in India

    Sep 1, 2020, 00:00

  • PNS1 Real-World DATA Collection in China: Challenges and Recommendations to Ensure DATA Quality

    Sep 1, 2020, 00:00

  • PND30 Breathing Training HAS Positive Effect on Attention in Children with ADHD

    Sep 1, 2020, 00:00

  • PCN28 Cost-Effectiveness Analysis of Avelumab for Treatment-Experienced and Treatment-Naïve Patients with Metastatic Merkel CELL Carcinoma in Taiwan

    Sep 1, 2020, 00:00

  • PGI8 Facility Size-Based Diagnostic Patterns of the Crohn's Disease-Associated Perianal Fistula Using an Employer-Based Health Insurance Claims Database in JAPAN

    Sep 1, 2020, 00:00

  • PNS15 Effects of Different Family Planning Policies on Cesarean Section Rates from 2009 to 2019: A Population-Based Registry in China

    Sep 1, 2020, 00:00

  • PCN104 Treatment Patterns and Health Resource Utilization in Patients with HR+/HER2- Locally Advanced or Metastatic Breast Cancer in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • PAM4 Cost-Effectiveness of Dangguixu-SAN for Patients with Mild to Moderate Ankle Sprain

    Sep 1, 2020, 00:00

  • Cost-Minimization Analysis of Ranibizumab Versus Aflibercept for Treating Saudi Patients With Visual Impairment Owing to Age-Related Macular Degeneration or Diabetic Macular Edema

    Sep 1, 2020, 00:00

  • PSY2 Evaluating Patient-Reported Outcomes and Work Productivity Among Patients with Psoriasis in Taiwan

    Sep 1, 2020, 00:00

  • PNS23 Setting Health Priorities in Low-Income and Middle-Income Countries in the ASIA-Pacific Region: The Case of Papua New Guinea

    Sep 1, 2020, 00:00

  • PCV7 Budget IMPACT Analysis on Fufang Xueshuantong Capsule in Treating Stable Angina Pectoris in China

    Sep 1, 2020, 00:00

  • PSU3 Clinical Outcomes and Economics Associated with Surgical Aortic Valve Replacement in Taiwan

    Sep 1, 2020, 00:00

  • PND11 Pharmacoeconomic Evaluation of Multiple Sclerosis Therapy Costs in Central ASIA

    Sep 1, 2020, 00:00

  • PIH18 Characterizing the IMPACT of PDE5I Use on the Health and Economic Burden of Erectile Dysfunction in the US, JAPAN, and China

    Sep 1, 2020, 00:00

  • PSS1 IMPACT of ITCH on SLEEP in Adults with Atopic Dermatitis: A Targeted Literature Review

    Sep 1, 2020, 00:00

  • PCN26 Disease Burden of ACUTE Myelogenous Leukemia UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PBI8 The Burden of Health Care Costs for Psoriasis Patients Treated with Biologics in South Korea

    Sep 1, 2020, 00:00

  • Productivity Loss in Patients With Chronic Diseases: A Pooled Economic Analysis of Hungarian Cost-of-Illness Studies [Editor's Choice]

    Sep 1, 2020, 00:00

  • PDG2 Survey of Usage of Molecular Targeted Drugs in LUNG Cancer Based on Claims DATA in JAPAN

    Sep 1, 2020, 00:00

  • PMH5 Assessing the IMPACT of New Policy for Patients with Mental Disorders on Cost of Drug Prescription: An Interrupted Time Series Analysis

    Sep 1, 2020, 00:00

  • PIN25 The IMPACT of Childhood Pneumococcal Conjugate Vaccine Immunisation on Pneumonia Admissions in Hong Kong: A Population-Based Interrupted Time Series Analysis from 2004-2017

    Sep 1, 2020, 00:00

  • PMU3 Medical Cost for Children with Infantile Hemangiomas in Southern China: Investigation Based on Medical Record DATA

    Sep 1, 2020, 00:00

  • PCN106 Treatment Patterns and Health Resource Utilization in Patients with Hepatocellular Cancer (HCC) Following Failure of Sorafenib in Real World Setting in Taiwan

    Sep 1, 2020, 00:00

  • PGI6 DISEASE BURDEN OF MODERATE TO SEVERE CROHN'S DISEASE UNDER CURRENT TREATMENT PATTERN IN CHINA

    Sep 1, 2020, 00:00

  • PNS9 The Potential IMPACT of External Reference Pricing Rules on Selected Drug Prices in China

    Sep 1, 2020, 00:00

  • PRS14 The IMPACT of Heart Failure on the Economic Burden of Various Phenotypes of Bronchial Obstructive Diseases

    Sep 1, 2020, 00:00

  • PMU6 Evaluation of the Application of the Hospital Management Program for Prevention and Treatment of Venous Thrombosis Based on Information Technology

    Sep 1, 2020, 00:00

  • PMU18 Budget IMPACT Analysis of the Eluvia Drug-Eluting Stent for Peripheral Artery Disease in Korea

    Sep 1, 2020, 00:00

  • PGI1 Systematic Review and Network Meta-Analysis of Infliximab, Adalimumab, Golimumab, Vedolizumab, Andtofacitinib for Moderate-to-Severe Ulcerative Colitis in ANTI-TNF-ALPHA-Naive Patients

    Sep 1, 2020, 00:00

  • PCN66 Utilization of EGFR and ALK Testing in LUNG Cancer Patients Using Real Wrold DATA from China

    Sep 1, 2020, 00:00

  • PDB27 Association between Health Characteristics and Mode of Insulin Administration Among Patients with Type II Diabetes in 2017 China National Health and Wellness Survey

    Sep 1, 2020, 00:00

  • PCV8 Cost-Utility and Budget IMPACT Analysis of Using Ranolazine in the Treatment of Refractory Stable Angina, an Iranian Heath System Perspective

    Sep 1, 2020, 00:00

  • PDB8 Short-TERM Cost-Effectiveness of Insulin Degludec/Insulin Aspart Versus Insulin Degludec in Patients with Type 2 Diabetes in China

    Sep 1, 2020, 00:00

  • PNS18 UNDER Threat of Covid-19, Is IT Against Humanitarianism to Adopt Sealed Management in Public Health Emergencies? a Survey Based on Chinese Public Attitudes Towards the Lockdown of Wuhan, China

    Sep 1, 2020, 00:00

  • PCV2 Volatile Anesthetics Versus TOTAL Intravenous Anesthesia in Patients Undergoing Coronary Artery Bypass Grafting: An Updated Meta-Analysis and Trial Sequential Analysis of Randomized Controlled Trials

    Sep 1, 2020, 00:00

  • PIN55 TREND in Medical Utilization and Treatment Status of CHB-Treated Patients in South Korea

    Sep 1, 2020, 00:00

  • PIT2 Descriptive Analysis of Complications, Length of STAY (LOS) and Costs of Surgical Fixation for Femoral Neck Fracture (FNF) in JAPAN

    Sep 1, 2020, 00:00

  • PIN9 Overview of Systematic Reviews of Economic Evaluations of Human Papillomavirus Vaccines

    Sep 1, 2020, 00:00

  • Donor Human Milk for Preterm Infants: A Cost-Consequence Analysis of Alternative Preservation Methods

    Sep 1, 2020, 00:00

  • PMU27 Comorbid Depression: IMPACT on Costs in Patients with EARLY Rheumatoid Arthritis

    Sep 1, 2020, 00:00

  • PCN90 Development of Time-Dependent Markov MODEL to Evaluate the Cost-Effectiveness of Treatment Options for Relapsed or Refractory Peripheral T-CELL Lymphoma in South Korea

    Sep 1, 2020, 00:00

  • PDB24 Characteristics and Treatment Patterns of ANTI-VEGF Use Among Patients with Diabetic Macular Edema in Taiwan: Real-World DATA from Population-Based Health Claims

    Sep 1, 2020, 00:00

  • PNS69 Measuring and Valuing Patient Experience

    Sep 1, 2020, 00:00

  • Barriers to Diabetes Adherence: Translation and Cultural Adaptation of the Instrument Into Arabic Context [Editor's Choice]

    Sep 1, 2020, 00:00

  • PNS60 Use of Artificial Intelligence with Distillersr Software in Selected Systematic Literature Reviews

    Sep 1, 2020, 00:00

  • PIN34 Effects of Meteorological Factors on the Daily Domestic New CASES of Coronavirus Disease (COVID-19) in Asian Countries: A MULTI-Country Generalized Additive Modeling Analysis

    Sep 1, 2020, 00:00

  • PCN44 Disease Burden of Follicular Lymphoma UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PMU20 Is There an Implicit Willingness-to-Pay Threshold in Singapore?

    Sep 1, 2020, 00:00

  • PCN29 Diagnosing and Classifying ACUTE Leukemia Patients through Immunophenotyping By FLOW Cytometry in Indonesia

    Sep 1, 2020, 00:00

  • PCN98 Assessment of Quality of Life in Patients with Metastatic Breast Cancer and Its Pharmaceutical Management in Tertiary Care Hospital: A Prospective Observational Study

    Sep 1, 2020, 00:00

  • PSU2 Clinical Outcomes and Economics Associated with Surgical Mitral Valve Replacement in Taiwan

    Sep 1, 2020, 00:00

  • PRS3 Health and Economic Burden Associated with 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Children in Australia

    Sep 1, 2020, 00:00

  • PIN43 IMPACT of CRE Infections on Hospital LOS and Mortality in ASIA

    Sep 1, 2020, 00:00

  • PSS2 Modelling Disease Burden in Patients with Myopia in China in 2030

    Sep 1, 2020, 00:00

  • PRO15 A Brief Introduction of DATA Governance for Congenital Anomalies Based on the Xiamen Registry of Pregnant Women and Offspring (REPRESENT): A Population-Based, LONG-TERM and Follow-up Database

    Sep 1, 2020, 00:00

  • PCV14 A Real World Clinical and Economic Evaluation of a Chinese Traditional Medicine (SONGLINGXUEMAIKANG) in the Management of Hypertension Patients in China

    Sep 1, 2020, 00:00

  • PMU23 Measurement of Health-Related Quality of Life in Australians with Progressive Onset Multiple Sclerosis

    Sep 1, 2020, 00:00

  • PND1 Depression And Sleep Quality Of People At Faculty Of Pharmaceutical Sciences, Burapha University, Thailand 2019

    Sep 1, 2020, 00:00

  • PUK1 Low-Flux Hemodialysis Versus High-Flux Hemodialysis for END-STAGE Kidney Disease Meta Analysis

    Sep 1, 2020, 00:00

  • PNS66 Content Validation of Translated Clinical Outcome Assessments Is Important: Recommendations from Experience in Japan and China

    Sep 1, 2020, 00:00

  • PMU10 Representativeness of a National Patient-Reported Survey in Korea: The Korea National Health and Wellness Survey

    Sep 1, 2020, 00:00

  • PIN46 Predicting Invasive Candidiasis in Intensive Care Units

    Sep 1, 2020, 00:00

  • PIN10 Cost IMPACT Analysis for Antibiotic Coated VS. NON-Coated Central Venous Catheters in India

    Sep 1, 2020, 00:00

  • PRO7 Economic Burden of Pompe Disease in China: Empirical Evidences and Simulation of Policy Effects

    Sep 1, 2020, 00:00

  • PCN89 Constructing Comparator Survival DATA: Simulated Versus Individual Patient DATA

    Sep 1, 2020, 00:00

  • PIN6 Rational Antibiotic Use in Outpatients with UPPER Respiratory TRACT Infections at District Health Promotion Hospital Panasnikom Chonburi

    Sep 1, 2020, 00:00

  • Idiopathic Pulmonary Fibrosis: Utilization of Health Services and Out-Of-Pocket Health Expenditures in Greece

    Sep 1, 2020, 00:00

  • PNS42 Health Care Professionals and Mobile Applications: A Systematic Review

    Sep 1, 2020, 00:00

  • PMU28 Utilization Patterns of a Japanese Biomedical Database, Ichushi, in Real-World Evidence Review: A Scoping Review

    Sep 1, 2020, 00:00

  • PNS58 The Efficiency Analysis of 19 Medical Centers in Taiwan

    Sep 1, 2020, 00:00

  • PDG15 Dollars DRIVE Decisions: TOTAL Healthcare Spending Best Predicts Country Selection for New Drug Launches

    Sep 1, 2020, 00:00

  • PNS17 Experience and Prevalence of Iqos Heated Tobacco Product Among Adolescents in Taiwan

    Sep 1, 2020, 00:00

  • PDB4 Study on Standard Criteria of SERUM Uric Acid and Factors of High Uric Acid in Children Using Claims Database in JAPAN

    Sep 1, 2020, 00:00

  • PNS20 Repercussions of Physical Exercises on Physical Health

    Sep 1, 2020, 00:00

  • PUK8 Cost-Effectiveness Analysis of Haemodiafiltration (HDF) Versus Haemodialysis (HD) in South Korea

    Sep 1, 2020, 00:00

  • PCV22 An Investigation of Health Technology Assessments (HTAS) on Transcatheter Aortic Valve Implantation (TAVI) over Time: As Evidence Evolves How Does HTA Respond?

    Sep 1, 2020, 00:00

  • PNS8 An Analysis of Utility Values USED in Cost Utility Studies Conducted from an Indian Perspective

    Sep 1, 2020, 00:00

  • PMS13 Incorporating Patient Preferences in Health Technology Assessment – Is Individual Simulation Modelling Useful?

    Sep 1, 2020, 00:00

  • PNS35 Health Service Utilization of Adults with Supplemental Private Health Insurance in South Korea: 2014-2016

    Sep 1, 2020, 00:00

  • PRO4 Lanreotide Acetate Injection for the Treatment of Acromegaly: A Budget IMPACT Analysis

    Sep 1, 2020, 00:00

  • PND8 Economic Evaluation of Clinical Pathways Management for Cerebral Infarction in RURAL Area of China

    Sep 1, 2020, 00:00

  • PCN97 Comparison of Disease-Specific (QLU-C10D) and Generic (EQ-5D) Utilities in Cost-Effectiveness Analysis

    Sep 1, 2020, 00:00

  • PCN45 Disease Burden of Breast Cancer UNDER the Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PNS12 A Study on Disabilities and Health-Related Direct Costs of Former Workers of Erdenet Mining Company

    Sep 1, 2020, 00:00

  • PMD4 Analysis of Costs, Length of Hospital STAY (LOS), Readmission and Quality of Life in Patients Undergoing Primary TOTAL Knee Arthroplasty (TKA) from China ATTUNE® Study

    Sep 1, 2020, 00:00

  • PND24 Target Identification and Drug Repurposing for Parkinson's Disease: A NOVEL Integrative Computational Approach

    Sep 1, 2020, 00:00

  • PDG5 Cost- Effectiveness Analysis between Aprepitant and Fosaprepitant in the Prevention of Chemotherapy-Induced Nausea and Vomiting in China

    Sep 1, 2020, 00:00

  • PIN3 Is Dolutegravir Cost Effective in Treating Patients Living with HIV?

    Sep 1, 2020, 00:00

  • PCN46 Disease Burden of Chronic Lymphocytic Leukemia/SMALL Lymphocytic Lymphomaunder Current Treatment Pattern in China

    Sep 1, 2020, 00:00

  • PIN28 Prediction of the PEAK Dates of the Numbers of COVID19 Pandemic Patients

    Sep 1, 2020, 00:00

  • PCN79 Willingness to Pay for Cancer Screening Testing in Malaysia

    Sep 1, 2020, 00:00

  • PIN12 Health and Economic IMPACT of 15-Valent Pneumococcal Conjugate Vaccine (V114) Serotypes in Adults 70 YEARS and Older in Australia

    Sep 1, 2020, 00:00

  • PAM6 Cost IMPACT Analysis for Coated VS NON-Coated CVC in China

    Sep 1, 2020, 00:00

  • PDB21 Safety and Efficacy Comparison between Insulin Degludec and Insulin Glargine

    Sep 1, 2020, 00:00

  • PMD7 Analysis of Medical Device Recall Reports in China from a Regulatory Science Perspective: Implications for Post-Marketing Surveillance

    Sep 1, 2020, 00:00

  • PMS7 Osteoporosis Diagnosis and Treatment Among Women in China: A Simulation Projection Model of Clinical and Economic Benefits through 2040

    Sep 1, 2020, 00:00

  • PRO17 Healthcare Resource Utilization (HCRU) in Patients with Palmoplantar Pustulosis (PPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PCN91 Penetration of Artificial Intelligence (AI) and Machine Learning (ML) in the Randomized Controlled Setting of Oncology

    Sep 1, 2020, 00:00

  • PIN13 Clinicoeconomic IMPACT of an Alcohol Based Hand RUB to Reduce Gram Negative MULTI Drug Resistant Bacteria: A Simulation Study in an Indian Healthcare Setting

    Sep 1, 2020, 00:00

  • PNS48 The Analysis of Sources of Utility Values USED in Cost-Utility Analyses in China

    Sep 1, 2020, 00:00

  • PIN36 Comparison of Vaccine Market Access Pathways in European and Asian Countries

    Sep 1, 2020, 00:00

  • PMD2 The Relationship between Sedatives and Risk of Ventilator-Associated Events

    Sep 1, 2020, 00:00

  • PIH2 Does Fertility Treatment Provide Good VALUE for Money? a Cost-Benefit Analysis

    Sep 1, 2020, 00:00

  • PDB19 Estimating National Burden of Disease Due to Type 2 Diabetes Considering Complications in Korea

    Sep 1, 2020, 00:00

  • PRO16 Healthcare Resource Utilization (HCRU) in Patients with Generalized Pustular Psoriasis (GPP) in JAPAN: A Claims Database Study

    Sep 1, 2020, 00:00

  • PIH3 Pharmacoeconomic Evaluation of ORAL Ibuprofen Versus Intravenous Ibuprofen in Preterm Infants with Patent Ductus Arteriosus in the Neonatal Intensive Care Units in Qatar

    Sep 1, 2020, 00:00

  • PMD9 Cost-Minimization Analysis of Robotic-Assisted Surgery for Gastric Cancer Patients in JAPAN

    Sep 1, 2020, 00:00

  • PMH2 The IMPACT of Major Depression on Productivity in South Korea

    Sep 1, 2020, 00:00

  • Assessing Patient Knowledge of Asthma Using a Newly Validated Tool

    Sep 1, 2020, 00:00

  • PMU29 Real World DATA Availability and Quality in ASIA Pacific. Assessment and Implications for Research and Healthcare Decision-Making

    Sep 1, 2020, 00:00

  • PIN44 Benefit Design Considerations during Emergencies: Lessons from Covid 19

    Sep 1, 2020, 00:00

  • PCN6 Thromboembolic Events Among Cancer Patients Treated with Chemotherapy at Adult Oncology Unit of Tikur Anbessa Specialized Hospital: A Retrospective CROSS-Sectional Study

    Sep 1, 2020, 00:00

  • PSU4 Cost Comparison and Budget IMPACT MODEL for Radical Prostatectomy in England

    Sep 1, 2020, 00:00

  • PNS50 Shall WE Need an AI Doctor? a Survey of AI-Technophobia Based on Chinese Public

    Sep 1, 2020, 00:00

  • PNS47 Capacity Building for Health Technology Assessment Implementation in Jordan

    Sep 1, 2020, 00:00

  • Comparing Quality of Life of General Population and Orthopedic Patients in Slovenia

    Sep 1, 2020, 00:00

  • PAM3 Cost-Effectiveness of Kinesiology Taping for Patients with Mild to Moderate Ankle Sprain

    Sep 1, 2020, 00:00

  • PUK9 Adherence to Drug Therapy in Chronic Kidney Disease: A Systematic Review

    Sep 1, 2020, 00:00

  • PBI6 Research on CAR-T’S Market Access and Reimbursement Strategy in China

    Sep 1, 2020, 00:00

  • PCN100 The Economic Burden of Gastric Cancer Mortality in Brazil/LATAM

    Sep 1, 2020, 00:00

  • PIN42 Current Trends in Covid-19 Testing Rates and Unmet NEEDS

    Sep 1, 2020, 00:00

  • PIN27 Projecting the Burden of Multidrug-Resistant Acinetobacter Baumannii Among Hospital-Associated Infections in China

    Sep 1, 2020, 00:00

  • PCN27 Study of Initial Treatment Cost for ACUTE Leukemia Patients in Vietnam

    Sep 1, 2020, 00:00

  • PRO18 Incidence, Mortality, Hospitalizations, and Expenditures for Pemphigus in Taiwan

    Sep 1, 2020, 00:00

  • PNS59 Reliability and Validity of the SF-12V2 Health-Related Quality of Life Survey and Disutilities Associated with Relevant Conditions in the U.S. Older Adult Population

    Sep 1, 2020, 00:00

  • PMD10 Cost-Utility Analysis of Robotic-Assisted Surgery for Prostate Cancer Patients in JAPAN

    Sep 1, 2020, 00:00

  • PDB10 Cost-Effectiveness of Canagliflozin Versus Sitagliptin in Chinese Patients with Type 2 Diabetes on Background Metformin Monotherapy

    Sep 1, 2020, 00:00

  • PIN49 Vaccination Rates Among the General Adult Population and High-Risk Groups in EU, US, JAPAN, South Korea and Taiwan

    Sep 1, 2020, 00:00

  • PMD15 Cost Utility Analysis of New Matrix Therapy Regenerating Agent (RGTA®) VS Good Wound Care for Patients with Advanced Diabetic Foot Ulcer

    Sep 1, 2020, 00:00
  • 1
  • 2
  • 3
  • 4
  • 5 (current)
  • 6
  • 7
  • 8
  • 9
  • 10
  • »